Approvals/TGA/APIDRA SOLOSTAR insulin glulisine (rbe) 100IU/mL 3mL solution for injection injector pen

Approved

STANDARD

APIDRA SOLOSTAR insulin glulisine (rbe) 100IU/mL 3mL solution for injection injector pen

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3218783dd78dbd23
Product Name: APIDRA SOLOSTAR insulin glulisine (rbe) 100IU/mL 3mL solution for injection injector pen
Artg Id: 132816
Artg Name: APIDRA SOLOSTAR insulin glulisine (rbe) 100IU/mL 3mL solution for injection injector pen
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2006-11-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a63042cf423fb3df3be10b37e5dd397b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8fc10c65f158c7ac80ef795ec9e511ae.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3218783dd78dbd23

Type

Standard